Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gentisin is a novel inhibitor of vascular smooth muscle cells (VSMC) proliferation with an IC50 value of 7.84 μM. Gentisin has mutagenic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 422.00 | |
5 mg | In stock | $ 981.00 | |
10 mg | In stock | $ 1,350.00 | |
25 mg | In stock | $ 1,960.00 | |
50 mg | In stock | $ 2,680.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 1,080.00 |
Description | Gentisin is a novel inhibitor of vascular smooth muscle cells (VSMC) proliferation with an IC50 value of 7.84 μM. Gentisin has mutagenic activity. |
Targets&IC50 | VSMC cells:7.84 μM |
In vitro | The anti-proliferative effect of Gentisin was confirmed by the quantification of DNA synthesis (BrdU incorporation) in VSMC. Cell death quantification (determined by LDH release in the culture medium) revealed that Gentisin was not cytotoxic in the investigated concentration range[1]. |
Source |
Molecular Weight | 258.23 |
Formula | C14H10O5 |
CAS No. | 437-50-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (309.80 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gentisin 437-50-3 Cell Cycle/Checkpoint DNA Damage/DNA Repair DNA/RNA Synthesis inhibit Inhibitor inhibitor